A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces that the first patient in the United States (U ...